bpc 157 ssri Research shows that 40-60% of people taking SSRIs experience emotional blunting, a reduced ability to feel both positive and negative emotions that goes far beyond the symptoms of depression itself. These University BPC 157 (Body Protection Compound-157)
Description
CordenPharma is a major CDMO with significant US operations, particularly in Colorado, that specializes in taking peptide projects from early development through commercial manufacturing

It appears to modulate the immune response by influencing cytokine activity and suppressing pro-inflammatory signaling

The dosing used in successful bone healing studies typically ranged from 0.01 mg/kg to 0.01 mg/kg body weight

Effects can be noticed within a few days to weeks, with optimal benefits appearing after 2-4 weeks of consistent use
